The major immunogenic epitope in APS patients that is closely associated with thrombosis is the β2GPI domain [62], but only 5% of COVID-19 patients with aPLs positivity had the β2GPI I domain [44]. This evidence concerns the gene APOH and deep vein thrombosis.